Amiran Gamkrelidze does not rule out the possible arrival of AstraZeneca representatives in Georgia to study the issue of the 27-year-old nurse

Amiran Gamkrelidze, director of the National Center for Disease Control, does not rule out the possibility that AstraZeneca representatives arrived in Georgia to study the incident in Akhaltsikhe.

As Gamkrelidze told reporters, the regulatory agency will send information to the world center for drug side effects in Sweden and the information will also be sent to the World Health Organization.

"In the case of this type of fatal complication, of course, there is an established rule, in Sweden there is a world center for drug side effects and the regulatory agency sends the information to them. AstraZeneca, the World Health Organization, will also be notified when the investigation is completed. First a short report is sent, then a more extensive one. Their representatives often come and study the situation on the spot, and this is not ruled out in this case either, because both the company and the World Health Organization are interested for the situation to be clarified and known", - Gamkrelidze said.